Cogent Biosciences (COGT) FCF Margin (2017 - 2020)
Cogent Biosciences' (COGT) quarterly FCF Margin came in at 3290.71% in Q3 2020, down 229218.0% year-on-year from N/an in Q4 2019, and down 108.73% on a QoQ basis from 1576.52% in Q2 2020.
Cogent Biosciences (COGT) FCF Margin (2017 - 2020) Analysis & Trends
Cogent Biosciences (COGT) has 4 years of FCF Margin data on file, last reported at 3290.71% in Q3 2020.
- On a quarterly basis, FCF Margin fell 229218.0% year-over-year to 3290.71% in Q3 2020; TTM through Dec 2020 was 455.47%, a 27081.0% decrease from a year earlier, with the FY2020 full-year figure at 455.47%, down 27081.0% from the prior year.
- FCF Margin for Q3 2020 stood at 3290.71%, down from 1576.52% in the prior quarter.
- Over the last five years, FCF Margin for COGT reached as high as 55.32% in Q4 2019 and fell as low as 3290.71% in Q3 2020.
- Historically, FCF Margin has averaged 633.78% across 4 years, with a median of 362.88% in 2018.
- On a YoY basis, FCF Margin climbed as much as 26638 bps in 2020 and fell as far as 229218 bps in 2020.
- Year by year, FCF Margin stood at 309.75% in 2017, then grew by 23 bps to 237.06% in 2018, then jumped by 77 bps to 55.32% in 2019, then plunged by 5848 bps to 3290.71% in 2020.
- Per Business Quant data, the three most recent FCF Margin figures were 3290.71% in Q3 2020, 1576.52% in Q2 2020, and 112.26% in Q1 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 10.45% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 43.35% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 23.53% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Cogent Biosciences | 6.87 Bn | 6.87 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | -3,290.71% |
| Jun 30, 2020 | -1,576.52% |
| Mar 31, 2020 | -112.26% |
| Dec 31, 2019 | -55.32% |
| Sep 30, 2019 | -998.53% |
| Jun 30, 2019 | -361.50% |
| Mar 31, 2019 | -378.64% |
| Dec 31, 2018 | -237.06% |
| Sep 30, 2018 | -374.99% |
| Jun 30, 2018 | -498.26% |
| Mar 31, 2018 | -362.88% |
| Dec 31, 2017 | -309.75% |
| Sep 30, 2017 | -247.45% |
| Jun 30, 2017 | -287.54% |
| Mar 31, 2017 | -415.33% |